Prostanoid receptor agonist compounds and methods of use for same
AssigneeAllergan, Inc.
InventorsJENNY W. WANG, DAVID F. WOODWARD, NEIL J. POLOSO, JULIA HERRMANN
Life of this patent
Estimating the term…
Abstract
Embodiments described herein are directed to prostanoid (IP) receptor agonist compounds, including cicaprost and certain prodrugs, and methods of preparation and use for the same. Certain embodiments are directed to the use of cicaprost and certain prodrugs in the treatment of topical and ocular conditions.
Claims17
A method of activating an IP receptor, wherein the method comprises administering a compound of the formula represented by Formula C, its enantiomers, diastereoisomers, tautomers, hydrates, solvates or a pharmaceutically acceptable salt thereof,
- wherein:
- A is selected from the group consisting of hydrogen, acetyl, and —COCH2CH3;
- and,
- R is selected from the group consisting of hydrogen, acetyl, and —COCH2CH3.
A method of promoting wound healing, comprising administering cicaprost to an eye.
Dependencies are inferred from the claim text.